Detalles de la búsqueda
1.
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost.
Strahlenther Onkol;
2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38829436
2.
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients.
Radiother Oncol;
183: 109632, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36963442
3.
Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer.
J Contemp Brachytherapy;
14(1): 15-22, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35233230
4.
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy.
Biomedicines;
10(10)2022 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289778
Resultados
1 -
4
de 4
1
Próxima >
>>